Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?
Metadata[+] Show full item record
Although African American men, men with a first-degree relative with prostate cancer (CaP), and older men constitute higher-risk subgroups, no well-designed randomized controlled trials are available that show PSA testing to improve mortality or quality of life for these or any other groups of men. A trend toward detecting more localized cancers and a possible decreasing mortality rate from CaP in all men may be related to PSA testing, lead-time bias, or both. (Grade of recommendation: C, based on inadequate reference standards and an unclear clinical decision rule.)
Journal of Family Practice, 51(2) 2002: 113.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.